BH4
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
VA Office of Research and Development
Overview
BH4 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
BH4 clinical trials
Explore related
Medical disclaimer. This page summarizes research about BH4 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.